Shuzhou Chu

619 citations
19 papers · 403 indexed · h-index 13
Topics
PI3K/AKT/mTOR signaling in cancer (5 papers)Cancer-related Molecular Pathways (3 papers)Caveolin-1 and cellular processes (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Shuzhou Chu

19 papers receiving 400 citations

Peers

Shuzhou Chu
Comparison fields: 5 of 64
  • Molecular Biology 288
  • Oncology 92
  • Cancer Research 92
  • Pulmonary and Respiratory Medicine 53
  • Cell Biology 45
Replace Can Lu with:
Can Lu China
Hala Elnakat Thomas United States
Qionghua Zhu China
Yitao Wang China
Chengyong Lei China
Kefeng Lei China
Yann Duchartre United States
Xiaoding Hu United States
Masumi Yoshie Japan
Shuzhou Chu relative to Can Lu China Can Lu's profile →
Citations per field
00.5×4.1×
Can Lu · 1×
Citations per year

Countries citing papers authored by Shuzhou Chu

Since Specialization
Citations

This map shows the geographic impact of Shuzhou Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuzhou Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuzhou Chu more than expected).

Fields of papers citing papers by Shuzhou Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuzhou Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuzhou Chu. The network helps show where Shuzhou Chu may publish in the future.

Co-authorship network of co-authors of Shuzhou Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuzhou Chu. A scholar is included among the top collaborators of Shuzhou Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuzhou Chu. Shuzhou Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 18
2 7
3 13
4 49
5
Primary synovial sarcoma of the larynx in a 14-year-old boy diagnosed by immunohistochemistry and fluorescence in situ hybridization: a rare case report.
4
6
High expression of heat shock protein 10 (Hsp10) is associated with poor prognosis in oral squamous cell carcinoma.
4
7 9
8 33
9 27
10 13
11 48
12 30
13
FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
12
14
Lipoadenoma of the adrenal gland: report of a rare entity and review of literature.
4
15 12
16 21
17 63
18
Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma.
15
19
Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.
21

About Shuzhou Chu

Shuzhou Chu is a scholar working on Cell Biology, Molecular Biology and Cancer Research, having authored 19 papers that have together received 403 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (3 papers) and Caveolin-1 and cellular processes (3 papers). The work is most often cited by research in Cancer Research (92 citations), Molecular Biology (288 citations) and Oncology (92 citations). Shuzhou Chu has collaborated with scholars based in China and United States. Frequent co-authors include Songqing Fan, Weiyuan Wang, Qiuyuan Wen, Lina Xu, Jiadi Luo, Lingjiao Chen, Guiyuan Xie, Hongjing Zang, Jinghe Li and Jiao Li. Their work appears in journals such as PLoS ONE, Theranostics and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026